These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 25347274)
1. Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-κB in mice. Xiao M; Zhu T; Zhang W; Wang T; Shen YC; Wan QF; Wen FQ Int J Mol Sci; 2014 Oct; 15(11):19355-68. PubMed ID: 25347274 [TBL] [Abstract][Full Text] [Related]
2. Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB. Zhu T; Wang DX; Zhang W; Liao XQ; Guan X; Bo H; Sun JY; Huang NW; He J; Zhang YK; Tong J; Li CY PLoS One; 2013; 8(2):e56407. PubMed ID: 23437127 [TBL] [Abstract][Full Text] [Related]
3. Emodin improves alveolar hypercoagulation and inhibits pulmonary inflammation in LPS-provoked ARDS in mice via NF-κB inactivation. Liu B; Cheng Y; Wu Y; Zheng X; Li X; Yang G; He T; Li S; Shen F Int Immunopharmacol; 2020 Nov; 88():107020. PubMed ID: 33182048 [TBL] [Abstract][Full Text] [Related]
4. Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARγ-dependent pathway. Zhu T; Zhang W; Feng SJ; Yu HP Int Immunopharmacol; 2016 May; 34():16-24. PubMed ID: 26910236 [TBL] [Abstract][Full Text] [Related]
5. Punicalagin ameliorates lipopolysaccharide-induced acute respiratory distress syndrome in mice. Peng J; Wei D; Fu Z; Li D; Tan Y; Xu T; Zhou J; Zhang T Inflammation; 2015 Apr; 38(2):493-9. PubMed ID: 25005005 [TBL] [Abstract][Full Text] [Related]
6. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways. Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602 [TBL] [Abstract][Full Text] [Related]
7. Ugonin M, a Helminthostachys zeylanica Constituent, Prevents LPS-Induced Acute Lung Injury through TLR4-Mediated MAPK and NF-κB Signaling Pathways. Wu KC; Huang SS; Kuo YH; Ho YL; Yang CS; Chang YS; Huang GJ Molecules; 2017 Apr; 22(4):. PubMed ID: 28368327 [No Abstract] [Full Text] [Related]
8. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression. Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503 [TBL] [Abstract][Full Text] [Related]
9. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B. Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940 [TBL] [Abstract][Full Text] [Related]
10. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice. Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426 [TBL] [Abstract][Full Text] [Related]
12. Effects of Zinc Finger Protein A20 on Lipopolysaccharide (LPS)-Induced Pulmonary Inflammation/Anti-Inflammatory Mediators in an Acute Lung Injury/Acute Respiratory Distress Syndrome Rat Model. Wu DQ; Wu HB; Zhang M; Wang JA Med Sci Monit; 2017 Jul; 23():3536-3545. PubMed ID: 28724884 [TBL] [Abstract][Full Text] [Related]
13. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro. Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871 [TBL] [Abstract][Full Text] [Related]
14. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway. Huang Y; Huang L; Zhu G; Pei Z; Zhang W J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668 [TBL] [Abstract][Full Text] [Related]
15. Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury. Lee JW; Park JW; Shin NR; Park SY; Kwon OK; Park HA; Lim Y; Ryu HW; Yuk HJ; Kim JH; Oh SR; Ahn KS Int J Mol Med; 2016 Sep; 38(3):834-44. PubMed ID: 27431288 [TBL] [Abstract][Full Text] [Related]
16. The therapeutic effects of Jaceosidin on lipopolysaccharide-induced acute lung injury in mice. Huang XL; Wei XC; Guo LQ; Zhao L; Chen XH; Cui YD; Yuan J; Chen DF; Zhang J J Pharmacol Sci; 2019 Jul; 140(3):228-235. PubMed ID: 31358372 [TBL] [Abstract][Full Text] [Related]
17. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition. Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201 [TBL] [Abstract][Full Text] [Related]
18. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway. Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201 [TBL] [Abstract][Full Text] [Related]
19. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice. Du ZA; Sun MN; Hu ZS Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747 [TBL] [Abstract][Full Text] [Related]
20. Preventive and therapeutic effects of Danhong injection on lipopolysaccharide induced acute lung injury in mice. Wan LM; Tan L; Wang ZR; Liu SX; Wang YL; Liang SY; Zhong JB; Lin HS J Ethnopharmacol; 2013 Aug; 149(1):352-9. PubMed ID: 23850708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]